We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLF icon
526
Sun Life Financial
SLF
$46.7B
$1.72M 0.02%
44,731
-5,297
-11% -$194K
XYZ
527
Block Inc
XYZ
$49B
$1.72M 0.02%
22,896
-169
-0.7% -$12.2K
CAH icon
528
Cardinal Health
CAH
$54.5B
$1.7M 0.02%
35,376
+9,222
+35% +$462K
ALGN icon
529
Align Technology
ALGN
$12.4B
$1.68M 0.02%
5,924
+315
+6% +$75.2K
CP icon
530
Canadian Pacific Kansas City
CP
$81.4B
$1.68M 0.02%
40,820
+2,100
+5% +$84.2K
WB icon
531
Weibo
WB
$1.95B
$1.67M 0.02%
27,000
+12,000
+80% +$745K
BBVA icon
532
Banco Bilbao Vizcaya Argentaria
BBVA
$146B
$1.67M 0.02%
+291
New +$1.71K
MGM icon
533
MGM Resorts International
MGM
$11.9B
$1.66M 0.02%
64,525
+5,574
+9% +$153K
TWTR
534
DELISTED
Twitter, Inc.
TWTR
$1.61M 0.02%
48,887
-225
-0.5% -$7.13K
ANGO icon
535
AngioDynamics
ANGO
$590M
$1.6M 0.02%
70,000
+14,000
+25% +$304K
LEG icon
536
Leggett & Platt
LEG
$1.47B
$1.59M 0.02%
37,573
+108
+0.3% +$4.54K
LITS
537
Lite Strategy Inc
LITS
$33.4M
$1.57M 0.02%
25,500
– –
KR icon
538
Kroger
KR
$36.6B
$1.56M 0.02%
63,616
-21,282
-25% -$583K
VCYT icon
539
Veracyte
VCYT
$4.45B
$1.55M 0.02%
+61,962
New +$1.18M
MAN icon
540
ManpowerGroup
MAN
$2.6B
$1.55M 0.02%
7,707
+771
+11% +$60.8K
VRSK icon
541
Verisk Analytics
VRSK
$28B
$1.52M 0.02%
11,412
-2,227
-16% -$271K
SJM icon
542
J.M. Smucker
SJM
$13.3B
$1.51M 0.02%
12,995
+8
+0.1% +$836
LRMR icon
543
Larimar Therapeutics
LRMR
$392M
$1.48M 0.02%
44,917
– –
EFX icon
544
Equifax
EFX
$22.1B
$1.47M 0.02%
12,419
+1,628
+15% +$174K
PBA icon
545
Pembina Pipeline
PBA
$29.1B
$1.47M 0.02%
39,911
-15,629
-28% -$553K
GPC icon
546
Genuine Parts
GPC
$17.8B
$1.47M 0.02%
13,085
-1,143
-8% -$118K
BF.B icon
547
Brown-Forman Class B
BF.B
$13.2B
$1.46M 0.02%
27,718
+4,707
+20% +$228K
MGA icon
548
Magna International
MGA
$18.9B
$1.45M 0.02%
29,712
+1,994
+7% +$101K
EDU icon
549
New Oriental
EDU
$8.1B
$1.44M 0.02%
16,000
-6,000
-27% -$452K
HRL icon
550
Hormel Foods
HRL
$14.2B
$1.44M 0.02%
32,083
+5,555
+21% +$238K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.